Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US StudyClin Genitourin Cancer 2021 Dec 01;19(6)480-490, ND Shore, R Ionescu-Ittu, F Laliberté, L Yang, D Lejeune, L Yu, MS Duh, M Mahendran, J Kim, SR Ghate
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.